The Parsemus Foundation

Parsemus Foundation, based in California, translates clinical research into actionable health information for medical providers and veterinarians. The organization maintains Parsemus.org as its primary publishing platform, producing research summaries and educational content on emerging treatments. Their recent coverage spans metformin for Long COVID prevention, intravenous iron for heart failure, and evidence updates on hormone therapy safety. The foundation's monthly newsletter synthesizes findings from clinical trials, preventive medicine research, and therapeutic innovations across human and animal health. Content development prioritizes interventions with established safety profiles, demonstrated efficacy data, and practical implementation potential. Their editorial approach emphasizes statistical validity, methodological rigor, and clear documentation of evidence quality. Parsemus specializes in highlighting underutilized treatments that show promise in peer-reviewed studies, particularly cost-effective options with broad accessibility. The foundation partners with academic researchers and clinicians to evaluate therapeutic applications, document real-world outcomes, and disseminate findings through their digital channels. Their work focuses on bridging laboratory discoveries, clinical validation, and practical implementation in medical settings.